BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7584073)

  • 21. Gene transfer technologies for the gene therapy of cancer.
    Vile R; Russell SJ
    Gene Ther; 1994 Mar; 1(2):88-98. PubMed ID: 7584073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninfectious gene transfer and expression systems for cancer gene therapy.
    Cooper MJ
    Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gelatin-based delivery systems for cancer gene therapy.
    Nezhadi SH; Choong PF; Lotfipour F; Dass CR
    J Drug Target; 2009 Dec; 17(10):731-8. PubMed ID: 19863194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene therapy of malignant tumors].
    Hauses M; Schackert HK
    Zentralbl Chir; 2000; 125 Suppl 1():41-6. PubMed ID: 10929646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress towards gene therapy for cancer.
    Marchisone C; Pfeffer U; Del Grosso F; Noonan DM; Santi L; Albini A
    J Exp Clin Cancer Res; 2000 Sep; 19(3):261-70. PubMed ID: 11144517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards safe, non-viral therapeutic gene expression in humans.
    Glover DJ; Lipps HJ; Jans DA
    Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral vector targeting for gene therapy.
    Günzburg WH; Fleuchaus A; Saller R; Salmons B
    Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy.
    Romano G; Claudio PP; Kaiser HE; Giordano A
    In Vivo; 1998; 12(1):59-67. PubMed ID: 9575427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Values and limits of adenoviral vectors for gene transfer in vivo].
    Briand P; Kahn A
    Pathol Biol (Paris); 1993 Oct; 41(8):663-71. PubMed ID: 8290309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral vectors for liver-directed gene therapy.
    Connelly S
    Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.